Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Non Operating Income: 2021-2024

Historic Non Operating Income for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to $14.2 million.

  • Immunocore Holdings' Non Operating Income fell 43.52% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 24.61%. This contributed to the annual value of $14.2 million for FY2024, which is 1682.83% up from last year.
  • Latest data reveals that Immunocore Holdings reported Non Operating Income of $14.2 million as of FY2024, which was up 1,682.83% from -$897,000 recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Non Operating Income registered a high of $14.2 million during FY2024, and its lowest value of -$1.7 million during FY2022.
  • In the last 3 years, Immunocore Holdings' Non Operating Income had a median value of -$897,000 in 2023 and averaged $3.9 million.
  • As far as peak fluctuations go, Immunocore Holdings' Non Operating Income slumped by 2,200.00% in 2022, and later soared by 1,682.83% in 2024.
  • Yearly analysis of 4 years shows Immunocore Holdings' Non Operating Income stood at -$73,000 in 2021, then plummeted by 2,200.00% to -$1.7 million in 2022, then spiked by 46.58% to -$897,000 in 2023, then skyrocketed by 1,682.83% to $14.2 million in 2024.